Hemant Mathai Mathew
Examiner (ID: 14805, Phone: (571)270-5604 , Office: P/3742 )
Most Active Art Unit | 3742 |
Art Unit(s) | 3742 |
Total Applications | 359 |
Issued Applications | 174 |
Pending Applications | 2 |
Abandoned Applications | 183 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5921607
[patent_doc_number] => 20060240109
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-26
[patent_title] => 'Cellulosic and lignocellulosic materials and compositions and composites made therefrom'
[patent_app_type] => utility
[patent_app_number] => 11/471924
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4302
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20060240109.pdf
[firstpage_image] =>[orig_patent_app_number] => 11471924
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/471924 | Cellulosic and lignocellulosic materials and compositions and composites made therefrom | Jun 20, 2006 | Issued |
Array
(
[id] => 5429085
[patent_doc_number] => 20090088395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-02
[patent_title] => 'CLARITHROMYCIN OR SALT THEREOF FOR USE IN THE TREATMENT OR PREVENTION OF PULMONARY DISEASE INDUCED BY DESTRUCTION OF PULMONARY ALVEOLI'
[patent_app_type] => utility
[patent_app_number] => 11/917845
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2606
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20090088395.pdf
[firstpage_image] =>[orig_patent_app_number] => 11917845
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/917845 | Clarithromycin or salt thereof for use in the treatment or prevention of pulmonary disease induced by destruction of pulmonary alveoli | Jun 20, 2006 | Issued |
Array
(
[id] => 5835504
[patent_doc_number] => 20060247336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-02
[patent_title] => 'Cellulosic and lignocellulosic materials and compositions and composites made therefrom'
[patent_app_type] => utility
[patent_app_number] => 11/472066
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4276
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20060247336.pdf
[firstpage_image] =>[orig_patent_app_number] => 11472066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/472066 | Cellulosic and lignocellulosic materials and compositions and composites made therefrom | Jun 20, 2006 | Issued |
Array
(
[id] => 5194374
[patent_doc_number] => 20070082858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-12
[patent_title] => 'Methods and compositions for the prevention of toxic side effects of aminoglycoside medications'
[patent_app_type] => utility
[patent_app_number] => 11/473300
[patent_app_country] => US
[patent_app_date] => 2006-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 40
[patent_no_of_words] => 38644
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20070082858.pdf
[firstpage_image] =>[orig_patent_app_number] => 11473300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/473300 | Methods and compositions for the prevention of toxic side effects of aminoglycoside medications | Jun 20, 2006 | Abandoned |
Array
(
[id] => 5760691
[patent_doc_number] => 20060211636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Macrolide Antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/422122
[patent_app_country] => US
[patent_app_date] => 2006-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 82370
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211636.pdf
[firstpage_image] =>[orig_patent_app_number] => 11422122
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/422122 | Macrolide Antibiotics | Jun 4, 2006 | Abandoned |
Array
(
[id] => 7688909
[patent_doc_number] => 20070105789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/441396
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 19714
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105789.pdf
[firstpage_image] =>[orig_patent_app_number] => 11441396
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/441396 | Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors | May 23, 2006 | Abandoned |
Array
(
[id] => 7688908
[patent_doc_number] => 20070105790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-05-10
[patent_title] => 'Pancreatic cancer treatment using Na+/K+ ATPase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/441397
[patent_app_country] => US
[patent_app_date] => 2006-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 28162
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20070105790.pdf
[firstpage_image] =>[orig_patent_app_number] => 11441397
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/441397 | Pancreatic cancer treatment using Na+/K+ ATPase inhibitors | May 23, 2006 | Abandoned |
Array
(
[id] => 5602915
[patent_doc_number] => 20060293260
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-28
[patent_title] => 'Useful high load concentrate compositions for control of ecto-and endo-parasites'
[patent_app_type] => utility
[patent_app_number] => 11/435994
[patent_app_country] => US
[patent_app_date] => 2006-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2899
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20060293260.pdf
[firstpage_image] =>[orig_patent_app_number] => 11435994
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/435994 | Useful high load concentrate compositions for control of ecto-and endo-parasites | May 16, 2006 | Abandoned |
Array
(
[id] => 7691479
[patent_doc_number] => 20070232554
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => '3,6-Bridged 9,12-oxolides'
[patent_app_type] => utility
[patent_app_number] => 11/435401
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16306
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20070232554.pdf
[firstpage_image] =>[orig_patent_app_number] => 11435401
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/435401 | 3,6-bridged 9,12-oxolides | May 15, 2006 | Issued |
Array
(
[id] => 5625881
[patent_doc_number] => 20060264386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof'
[patent_app_type] => utility
[patent_app_number] => 11/435153
[patent_app_country] => US
[patent_app_date] => 2006-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7676
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264386.pdf
[firstpage_image] =>[orig_patent_app_number] => 11435153
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/435153 | Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof | May 15, 2006 | Abandoned |
Array
(
[id] => 5889878
[patent_doc_number] => 20060276418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Multidrug resistant anticancer anthracyclines'
[patent_app_type] => utility
[patent_app_number] => 11/432901
[patent_app_country] => US
[patent_app_date] => 2006-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7391
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0276/20060276418.pdf
[firstpage_image] =>[orig_patent_app_number] => 11432901
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/432901 | Multidrug resistant anticancer anthracyclines | May 11, 2006 | Issued |
Array
(
[id] => 5142437
[patent_doc_number] => 20070004653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-04
[patent_title] => 'Stable lyophilized anthracycline glycosides'
[patent_app_type] => utility
[patent_app_number] => 11/433026
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10275
[patent_no_of_claims] => 125
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20070004653.pdf
[firstpage_image] =>[orig_patent_app_number] => 11433026
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/433026 | Stable lyophilized anthracycline glycosides | May 10, 2006 | Abandoned |
Array
(
[id] => 5786507
[patent_doc_number] => 20060205683
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same'
[patent_app_type] => utility
[patent_app_number] => 11/432983
[patent_app_country] => US
[patent_app_date] => 2006-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4389
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205683.pdf
[firstpage_image] =>[orig_patent_app_number] => 11432983
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/432983 | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same | May 10, 2006 | Abandoned |
Array
(
[id] => 4759941
[patent_doc_number] => 20080312167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => '4\'\' Amino Linked Macrolides Useful for the Treatment of Microbial Infections'
[patent_app_type] => utility
[patent_app_number] => 11/913853
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19166
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312167.pdf
[firstpage_image] =>[orig_patent_app_number] => 11913853
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/913853 | 4'' Amino Linked Macrolides Useful for the Treatment of Microbial Infections | May 8, 2006 | Abandoned |
Array
(
[id] => 289065
[patent_doc_number] => 07547679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-16
[patent_title] => 'Ether linked macrolides useful for the treatment of microbial infections'
[patent_app_type] => utility
[patent_app_number] => 11/431696
[patent_app_country] => US
[patent_app_date] => 2006-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28251
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/547/07547679.pdf
[firstpage_image] =>[orig_patent_app_number] => 11431696
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/431696 | Ether linked macrolides useful for the treatment of microbial infections | May 8, 2006 | Issued |
Array
(
[id] => 4823089
[patent_doc_number] => 20080227732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Treatment and Control of Severe Infections Including Cystic Fibrosis'
[patent_app_type] => utility
[patent_app_number] => 11/914284
[patent_app_country] => US
[patent_app_date] => 2006-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7019
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227732.pdf
[firstpage_image] =>[orig_patent_app_number] => 11914284
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/914284 | Treatment and Control of Severe Infections Including Cystic Fibrosis | May 7, 2006 | Abandoned |
Array
(
[id] => 5625882
[patent_doc_number] => 20060264387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-23
[patent_title] => 'Macrolides'
[patent_app_type] => utility
[patent_app_number] => 11/429678
[patent_app_country] => US
[patent_app_date] => 2006-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12689
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20060264387.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429678
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429678 | Macrolides | May 7, 2006 | Issued |
Array
(
[id] => 5784468
[patent_doc_number] => 20060204559
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent'
[patent_app_type] => utility
[patent_app_number] => 11/429547
[patent_app_country] => US
[patent_app_date] => 2006-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9386
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20060204559.pdf
[firstpage_image] =>[orig_patent_app_number] => 11429547
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/429547 | Fast dissolving orally consumable films containing a taste masking agent | May 4, 2006 | Issued |
Array
(
[id] => 5662117
[patent_doc_number] => 20060252713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-09
[patent_title] => 'Spirocyclic bicyclolides'
[patent_app_type] => utility
[patent_app_number] => 11/416739
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16223
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0252/20060252713.pdf
[firstpage_image] =>[orig_patent_app_number] => 11416739
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/416739 | Spirocyclic bicyclolides | May 2, 2006 | Issued |
Array
(
[id] => 847222
[patent_doc_number] => 07384922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-06-10
[patent_title] => '6-11 bridged oxime erythromycin derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/416609
[patent_app_country] => US
[patent_app_date] => 2006-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15640
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/384/07384922.pdf
[firstpage_image] =>[orig_patent_app_number] => 11416609
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/416609 | 6-11 bridged oxime erythromycin derivatives | May 2, 2006 | Issued |